Status:

COMPLETED

Contingency Management for Cannabis Use for Persons With HIV

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Collaborating Sponsors:

The University of Texas Health Sciences Center, Houston

National Institute on Drug Abuse (NIDA)

Conditions:

Marijuana

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to determine the feasibility and impact of 28-days of monitored abstinence from cannabis use on symptoms of depression and anxiety, pain, sleep, cannabis use withdrawal, H...

Eligibility Criteria

Inclusion

  • HIV-positive (confirmed via HIV medication or relevant HIV labs in subject's name)
  • Self-report of cannabis use at least once per week in the 6-month period prior to consent
  • Provide a positive urine toxicology (UTOX) screen for cannabis
  • Not seeking treatment for cannabis use
  • Willing to stop using cannabis for 28 days and attend eight study visits over six weeks.
  • Ability and willingness to provide inform consent
  • English fluency

Exclusion

  • Currently receiving treatment for cannabis or other drug use disorder
  • Diagnosed or receiving treatment for a current major depressive or anxiety disorder
  • Diagnosed with any current alcohol or substance use disorder (excluding nicotine) using the Structured Clinical Interview for Clinical Disorders (SCID) Interview (22)
  • Positive UTOX screen for opioids
  • Having a medical, psychiatric, occupational, or other condition that, in the judgment of the study physician, would make participation difficult or unsafe.

Key Trial Info

Start Date :

August 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2025

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04866004

Start Date

August 1 2021

End Date

July 31 2025

Last Update

September 4 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Center for Neurobehavioral Research on Addiction

Houston, Texas, United States, 77054

2

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229